283 related articles for article (PubMed ID: 23295930)
1. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
Wu K; Yau YC; Matukas L; Waters V
Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
Pompilio A; Crocetta V; Verginelli F; Di Bonaventura G
FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27242375
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
5. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
[TBL] [Abstract][Full Text] [Related]
6. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
Rutter WC; Burgess DR; Burgess DS
Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
Pollini S; Di Pilato V; Landini G; Di Maggio T; Cannatelli A; Sottotetti S; Cariani L; Aliberti S; Blasi F; Sergio F; Rossolini GM; Pallecchi L
PLoS One; 2018; 13(10):e0203941. PubMed ID: 30273348
[TBL] [Abstract][Full Text] [Related]
8.
Alcaraz E; Centrón D; Camicia G; Quiroga MP; Di Conza J; Passerini de Rossi B
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258754
[No Abstract] [Full Text] [Related]
9. Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients.
Tom SK; Yau YC; Beaudoin T; LiPuma JJ; Waters V
Antimicrob Agents Chemother; 2016 Jan; 60(1):650-2. PubMed ID: 26525791
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms.
Sun E; Liang G; Wang L; Wei W; Lei M; Song S; Han R; Wang Y; Qi W
Braz J Infect Dis; 2016; 20(4):365-73. PubMed ID: 27183359
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
Wang CH; Yu CM; Hsu ST; Wu RX
J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Duan Z; Qin J; Liu Y; Li C; Ying C
BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
[TBL] [Abstract][Full Text] [Related]
13. Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.
Milne KE; Gould IM
Antimicrob Agents Chemother; 2012 Aug; 56(8):4071-7. PubMed ID: 22585220
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin.
Qamruddin AO; Alkawash MA; Soothill JS
Antimicrob Agents Chemother; 2005 Oct; 49(10):4425-6. PubMed ID: 16189141
[No Abstract] [Full Text] [Related]
15. Effect of antimicrobials on
Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
[No Abstract] [Full Text] [Related]
16. Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.
Biswas S; Dubus JC; Reynaud-Gaubert M; Stremler N; Rolain JM
Eur J Clin Microbiol Infect Dis; 2013 Nov; 32(11):1461-4. PubMed ID: 23719852
[TBL] [Abstract][Full Text] [Related]
17. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.
Anderson SW; Stapp JR; Burns JL; Qin X
J Clin Microbiol; 2007 Feb; 45(2):529-35. PubMed ID: 17135443
[TBL] [Abstract][Full Text] [Related]
18. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
[TBL] [Abstract][Full Text] [Related]
19. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
Lobo LJ; Tulu Z; Aris RM; Noone PG
Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
[TBL] [Abstract][Full Text] [Related]
20. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Pompilio A; Crocetta V; Confalone P; Nicoletti M; Petrucca A; Guarnieri S; Fiscarelli E; Savini V; Piccolomini R; Di Bonaventura G
BMC Microbiol; 2010 Apr; 10():102. PubMed ID: 20374629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
